Invitation to presentation of the year-end report 2023

Oncopeptides AB (publ) will publish the report for the fourth quarter and the 2023 year-end report, at 08:00 CET on February 27, 2024. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session at 09:00 CET on the same day.

The presentation will be hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. The webcast was held in English and is published below.

Information for participants

If you wish to participate via webcast please use the link below.

If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

For more information, please contact:

David Augustsson, Director of Corporate Affairs, Oncopeptides AB (publ)
Cell phone: +46 76 229 38 68